Radiation therapy delivered to or near the eye can cause side effects ranging from persistent dry eye and eyelid irritation in the short term to cataracts, retinal damage, and vision loss over months or years. The specific risks depend heavily on the dose reaching each structure of the eye, and the timeline can stretch from weeks after treatment to a decade or more. What makes eye radiation toxicity particularly tricky is its layered nature: the surface of the eye, the lens, the retina, and the optic nerve each respond differently and on different schedules.
Dry Eye and Surface Damage in the Early Weeks
The most common early complaint after radiation near the eye is dry eye. This happens because radiation damages the meibomian glands, tiny oil-producing glands in the eyelids that keep the tear film stable. When those glands degrade, tears evaporate faster and the eye surface dries out. In patients treated for lymphoma around the eye, meibomian gland damage worsened steadily after radiation, with dry eye symptoms peaking right after treatment. Patients whose tumors were deeper in the orbit had more severe and persistent symptoms than those with surface-level disease.1PubMed Central. Effects of radiation therapy on the meibomian glands and dry eye in patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma
This gland damage is not limited to people treated for eye cancers. Roughly a quarter of patients treated with radiation for head and neck cancers showed dry eye symptoms and measurable meibomian gland loss, even though their eyes were not the treatment target.2Scientific Reports. Alterations in meibomian glands in patients treated with intensity-modulated radiotherapy for head and neck cancer What surprised researchers is how little radiation it takes: even eyes that received less than 30 Gy showed significantly more gland loss and shorter tear-film stability than eyes that had never been irradiated.3Cornea. Meibomian Gland Dysfunction Associated With Periocular Radiotherapy The degree of gland dropout correlated with total radiation dose and with the patient’s age, meaning older patients lost glands faster at the same dose.
Corneal complications are also common early on. An observational study across several tumor types found that nearly half of treated eyes developed some form of corneal problem, though the rate varied by diagnosis and dose. Eyes that received a maximum dose above 40 Gy were roughly twice as likely to develop corneal complications as those receiving less.4PubMed Central. Ocular Complications After Radiation Therapy: An Observational Study In severe cases, radiation can destroy the limbal stem cells that continuously regenerate the cornea’s surface, leading to clouding, blood vessel invasion, and significant vision impairment.5PubMed Central. Presentation, diagnosis and management of limbal stem cell deficiency
Cataracts From Radiation
The lens of the eye is one of the most radiation-sensitive structures in the body. Radiation-induced cataracts have been recognized for decades, but the threshold dose keeps dropping as more data come in. Recent research suggests that lens clouding can develop at doses around 1 Gy or even below, far lower than previously assumed.6Experimental Eye Research. Sensitivity and latency of ionising radiation-induced cataract What changes with dose is mostly timing: higher doses produce cataracts sooner, sometimes within a year or two, while low-dose cataracts can take many years to become noticeable. Because cataract surgery is widely available and effective, radiation cataracts are generally considered manageable rather than devastating, but they are worth knowing about because they are among the most predictable long-term consequences of eye radiation.
Radiation Retinopathy
This is where the stakes get higher. Radiation retinopathy is damage to the delicate blood vessels that supply the retina, and it is the side effect most likely to cause serious, permanent vision loss. The process starts silently: radiation kills the endothelial cells lining tiny retinal blood vessels, causing those vessels to close off over time. As more capillaries shut down, the retina becomes starved of oxygen. The body responds by growing fragile new blood vessels that leak and bleed, leading to swelling in the macula, hemorrhages, and in advanced cases, retinal detachment.7PubMed Central. Radiation Retinopathy: Detection and Management Strategies
The initial phase is asymptomatic. Patients feel nothing while the vascular remodeling and chronic ischemia develop quietly, which is part of what makes radiation retinopathy dangerous. By the time symptoms appear, the damage is often already advanced and difficult to reverse.8PubMed. Vascular dysfunctions during radiation retinopathy A systematic review of patients treated with radiation for brain, head, and neck tumors found that retinopathy was observed when prescribed tumor doses exceeded 50 Gy, and that the dose reaching the optic chiasm (where the optic nerves cross) was significantly associated with retinopathy risk.9PubMed Central. Radiation-Induced Retinopathy and Optic Neuropathy after Radiation Therapy for Brain, Head, and Neck Tumors: A Systematic Review
Optic Nerve Damage
Radiation-induced optic neuropathy is rarer than retinopathy but more feared, because it tends to strike suddenly and with little warning. It typically shows up as a painless, abrupt loss of vision in one eye, appearing months to years after radiation.10PubMed Central. Radiation-Induced Optic Neuropathy: Literature Review In a single-center study, over 80% of affected eyes showed enhancement of the optic nerve on MRI, usually in the portion running inside the skull, and a third of those eyes also had visible nerve swelling.11PubMed Central. Clinical characteristics of radiation-induced optic neuropathy: A single-center retrospective study
The same systematic review that examined retinopathy found optic neuropathy occurred at a rate of about 4.5% when prescribed tumor doses were above 50 Gy, compared with about 1.7% below that threshold, a statistically significant difference. Doses reaching the retina, the optic nerve, and the chiasm were all associated with increased risk.9PubMed Central. Radiation-Induced Retinopathy and Optic Neuropathy after Radiation Therapy for Brain, Head, and Neck Tumors: A Systematic Review Several factors push the risk higher at any given dose: older age, pre-existing tumor compression on the optic nerve, chemotherapy given alongside radiation, and prior courses of radiation.12PubMed. Radiation-induced optic neuropathy
Glaucoma After Radiation
Radiation can also raise pressure inside the eye, particularly through a mechanism called neovascular glaucoma. When the retina becomes severely ischemic from radiation damage, the new abnormal blood vessels that sprout can grow into the drainage structures of the eye and block fluid outflow, causing pressure to spike. Evidence suggests this happens relatively quickly, within a few years after high-dose treatment, and appears to behave as a threshold effect requiring at least 5 Gy and possibly much higher doses. There is limited evidence for glaucoma risk from low-dose or low-dose-rate exposures.13PubMed Central. Glaucomagenesis following ionizing radiation exposure
Why Children Face Additional Risks
Children treated with radiation to the eye, most commonly for retinoblastoma, face a unique problem on top of the tissue damage adults experience: radiation stunts the growth of the bones around the eye. The orbit is still developing during childhood, and radiation disrupts that growth. Studies have found significant growth retardation of irradiated orbits compared with the non-irradiated side, and treatment before six months of age causes more severe underdevelopment than treatment at older ages.14PubMed. Quantification of orbital and mid-facial growth retardation after megavoltage external beam irradiation in children with retinoblastoma High-dose orbital radiation above 35 Gy and surgical eye removal both independently harmed orbital development in long-term retinoblastoma survivors.15PubMed. Orbital development in long-term survivors of retinoblastoma This is one reason pediatric oncologists have increasingly shifted toward chemotherapy-based approaches and focal treatments to avoid or reduce orbital radiation in young children.
Treating Radiation Retinopathy With Injections
Once radiation retinopathy develops, the main treatment involves injecting drugs directly into the eye to shut down the abnormal blood vessel growth. These anti-VEGF drugs, the same class used for age-related macular degeneration, have become the standard first-line approach. A 10-year study found that after repeated injections, 80% of patients kept their vision within two lines of where it started or better, with treatment intervals averaging about three years.16PubMed. Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study
A meta-analysis comparing anti-VEGF injections to other treatment strategies found that anti-VEGF therapy produced better improvements in visual acuity and greater reductions in retinal thickness and the area of blood vessel dropout.17PubMed. Efficacy of Intravitreal Injections Anti-Vascular Endothelial Growth Factor Treatment for Radiation Retinopathy: A Systematic Review and Meta-analysis That said, not every patient responds, and some develop resistance after multiple injections. In resistant cases, steroid implants injected into the eye have shown promise, and combining anti-VEGF drugs with steroids has resolved swelling in patients who did not respond to either drug alone, likely because the two work through different pathways.18PubMed. The variable efficacy of intravitreal bevacizumab and triamcinolone acetonide for cystoid macular edema due to radiation retinopathy Sustained-release steroid implants have also been used off-label for stubborn cases.19PubMed Central. Effect of intravitreal dexamethasone implant on the contralateral eye in recalcitrant radiation maculopathy
Catching Damage Before Symptoms Appear
Because radiation retinopathy is silent in its early stages, researchers have invested heavily in finding ways to detect it before patients notice vision changes. Advanced retinal imaging can now pick up subtle vascular damage well before clinical symptoms emerge. In a study of children who had received radiation but had no visible retinopathy, imaging revealed an enlarged foveal avascular zone, a sign that capillaries were already dropping out, compared with unirradiated controls. Even their visual acuity, while still good, was slightly worse than that of the control group.20PubMed. Early Detection of Radiation Retinopathy in Pediatric Patients Undergoing External Beam Radiation Using Optical Coherence Tomography Angiography This kind of subclinical detection matters because starting treatment earlier, before the retina suffers irreversible damage, likely improves outcomes. Newer imaging techniques allow clinicians to track the ultrastructural changes that accumulate after radiation exposure with much greater precision than traditional eye exams alone.21American Journal of Ophthalmology Case Reports. Longitudinal optical coherence tomography angiography (OCT-A) in a patient with radiation retinopathy following plaque brachytherapy for uveal melanoma
Occupational Exposure and the Eyes
Radiation side effects on the eye are not limited to cancer patients. People who work around radiation, such as interventional radiologists, nuclear plant workers, and some industrial inspectors, accumulate low-dose exposure over years. A study of radiation workers found a clear dose-response pattern: the more cumulative exposure, the worse their dry eye symptoms, tear production, and tear film stability compared with unexposed controls. Corneal endothelial cell density, a marker of the cornea’s long-term health, was also reduced in exposed workers.22PubMed. The impact of prolonged low-dose radiation exposure on tear function and corneal endothelial parameters in radiation workers Interestingly, some changes like cornea guttata, small bumps on the inner corneal surface, were more common in exposed individuals but did not track neatly with annual dose, suggesting either a threshold effect or some element of randomness in how the cornea responds to chronic low-level radiation.
Shielding and Emerging Technologies
When radiation must be delivered near the eye for eyelid or facial cancers, physical shielding is the first line of defense for the lens and cornea. Internal eye shields placed under the eyelid during treatment can block the beam from reaching deeper structures. Shields made of tungsten have been shown to outperform traditional lead shields, providing better protection while also reducing the backscatter radiation that bounces off the shield and hits the overlying eyelid tissue.23PubMed. Evaluation of eye shields made of tungsten and aluminum in high-energy electron beams
On the technology frontier, FLASH radiation therapy, which delivers the entire dose in an extremely short burst rather than over minutes, is generating excitement for eye-sparing potential. In preclinical studies, FLASH proton therapy preserved corneal transparency comparable to unirradiated eyes, while the same dose delivered at conventional rates caused progressive corneal destruction within months. Retinal function was also dramatically better preserved with FLASH delivery: conventional-rate eyes lost about three quarters of their photoreceptor function by five months, while FLASH-treated eyes retained near-normal responses across all retinal layers. The anti-tumor effect remained equivalent between the two approaches.24PubMed. FLASH Proton Radiation Therapy Preserves Ocular Structure and Function Without Compromising Antitumor Efficacy These results are from animal models and have not yet been confirmed in human clinical trials, but they represent one of the most promising leads for reducing eye radiation toxicity in the future.
Quality of Life After Eye Radiation
Beyond the clinical measurements, what patients often want to know is how radiation will affect their daily lives. A comparison of patients treated with radiation versus surgical eye removal for choroidal melanoma found few differences in overall quality of life between the two groups. Radiation-treated patients scored slightly higher on vitality and mental health measures, but the two groups were essentially equivalent on vision-specific questionnaires, general well-being, and willingness to trade time for better health.25Archives of Ophthalmology. Treatment Choice and Quality of Life in Patients With Choroidal Melanoma For patients deciding between radiation and surgery, the reassuring finding is that neither path clearly dominates on quality-of-life grounds; the choice more often comes down to tumor characteristics and individual anatomy. Unsurprisingly, the patients who fared best on follow-up quality-of-life measures were those who preserved the most visual acuity, regardless of treatment type.26PubMed Central. Quality of life among people with eye cancer: a systematic review from 2012 to 2022
Plaque Brachytherapy and Its Own Set of Risks
Plaque brachytherapy, where a small radioactive disc is temporarily sutured onto the wall of the eye to treat tumors like uveal melanoma, concentrates radiation very close to the tumor while sparing more distant tissue. But the structures nearest the plaque still absorb significant doses. Documented complications include scleral thinning or breakdown at the plaque site, misalignment of the eyes from muscle damage, cataracts, glaucoma, and retinal damage.27PubMed Central. Complications and adverse events of plaque brachytherapy for ocular melanoma In rare cases of severe scleral breakdown after brachytherapy, hyperbaric oxygen therapy has been used to promote revascularization and healing, with reported success in restoring the sclera to near-normal thickness after a course of sessions.28PubMed. Hyperbaric oxygen therapy for beta-radiation-induced scleral necrosis The trade-off with brachytherapy is usually worth it: it preserves the eye itself, which external beam radiation and enucleation may not, but patients need close monitoring for years afterward because the complications develop on a delayed timeline similar to external-beam retinopathy.